SecuritySGEN / Seattle Genetics, Inc.
InstitutionNational Planning Corp
Shares0
Value $ 0

National Planning Corp closes passive position in SGEN / Seattle Genetics, Inc.

February 14, 2018 - National Planning Corp has filed a 13F-HR form disclosing ownership of 0 shares of Seattle Genetics, Inc. (NASDAQ:SGEN) with total holdings valued at $0 USD as of December 31, 2017. National Planning Corp had filed a previous 13F-HR/A on November 22, 2017 disclosing 94,430 shares of Seattle Genetics, Inc. at a value of $5,138,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.

Other investors with closed positions include Redmile Group, LLC, Rock Springs Capital Management LP, Susquehanna International Group, Llp, Two Sigma Investments Llc, and Quantitative Investment Management, LLC.

Seattle Genetics, Inc. has declared a standard industrial code (sic) of 2836 which is the "Biological Products, Except Diagnostic Substances (Biotech)" industry. National Planning Corp's top industries are "Automotive Dealers And Gasoline Service Stations" (sic 55), "Home Furniture, Furnishings, And Equipment Stores" (sic 57), and "Fabricated Metal Products, Except Machinery And Transportation Equipment" (sic 34).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2017-12-31 13F-HR SEATTLE GENETICS COM 812578102 0 -100.00 0 -100.00
2017-09-30 13F-HR/A-1 SEATTLE GENETICS COM 812578102 53.31 94,430 -14.92 5,138 -11.34 -883 226 3.90
2017-09-30 13F-HR SEATTLE GENETICS COM 812578102 92,555 5,363
2017-06-30 13F-HR SEATTLE GENETICS COM 812578102 57.70 110,990 -0.85 5,795 -18.07 -55 -1,223 -17.29
2017-03-31 13F-HR SEATTLE GENETICS COM 812578102 61.59 111,940 -1.06 7,073 4.21 -74 360 5.30
2016-12-31 13F-HR SEATTLE GENETICS COM 812578102 59.86 113,140 -2.75 6,787 -2.33 -191 29 0.42
2016-09-30 13F-HR SEATTLE GENETICS COM 812578102 54.12 116,335 -0.44 6,949 22.58 -28 1,308 23.07
2016-06-30 13F-HR SEATTLE GENETICS COM 812578102 41.06 116,845 -3.63 5,669 39.12 -181 1,775 43.55
2016-03-31 13F-HR SEATTLE GENETICS COM 812578102 32.73 121,245 -3.44 4,075 1.90 -141 217 5.43
2015-12-31 13F-HR SEATTLE GENETICS COM 812578102 38.06 125,560 -5.51 3,999 -32.04 -279 -1,606 -27.30
2015-09-30 13F-HR SEATTLE GENETICS COM 812578102 44.65 132,885 0.44 5,884 -1.19 26 -97 -1.63
2015-06-30 13F-HR SEATTLE GENETICS COM 812578102 40.01 132,300 -3.39 5,955 24.24 -186 1,348 28.12
2015-03-31 13F-HR SEATTLE GENETICS COM 812578102 16,092.50 136,940 -13.22 4,793 -99.91 -335,690 -4,732,787 -93.29
2014-12-31 13F-HR SEATTLE GENETICS COM 812578102 16,092.89 157,800 2.94 5,073,270 92,410.39 72,418 4,995,368 91,089.86
2014-09-30 13F-HR SEATTLE GENETICS COM 812578102 153,300 5,484


CUSIP: 812578102